Look Up > Drugs > Metyrosine
Metyrosine
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(me TYE roe seen)

U.S. Brand Names
Demser®

Generic Available

No


Synonyms
AMPT; OGMT

Pharmacological Index

Tyrosine Hydroxylase Inhibitor


Use

Short-term management of pheochromocytoma before surgery, long-term management when surgery is contraindicated or when malignant


Pregnancy Risk Factor

C


Contraindications

Hypertension of unknown etiology, known hypersensitivity to metyrosine


Warnings/Precautions

Maintain fluid volume during and after surgery; use with caution in patients with impaired renal or hepatic function


Adverse Reactions

>10%:

Central nervous system: Drowsiness, extrapyramidal symptoms

Gastrointestinal: Diarrhea

1% to 10%:

Endocrine & metabolic: Galactorrhea, edema of the breasts

Gastrointestinal: Nausea, vomiting, xerostomia

Genitourinary: Impotence

Respiratory: Nasal congestion

<1%: Lower extremity edema, depression, hallucinations, disorientation, parkinsonism, urticaria, urinary problems, anemia, eosinophilia, hematuria, hyperstimulation after withdrawal


Overdosage/Toxicology

Signs of overdose include sedation, fatigue, tremor; reducing dose or discontinuation of therapy usually results in resolution of symptoms


Drug Interactions

Phenothiazines, haloperidol may potentiate EPS


Mechanism of Action

Blocks the rate-limiting step in the biosynthetic pathway of catecholamines. It is a tyrosine hydroxylase inhibitor, blocking the conversion of tyrosine to dihydroxyphenylalanine. This inhibition results in decreased levels of endogenous catecholamines. Catecholamine biosynthesis is reduced by 35% to 80% in patients treated with metyrosine 1-4 g/day.


Pharmacodynamics/Kinetics

Half-life: 7.2 hours

Elimination: Following oral absorption, excreted primarily unchanged in urine


Usual Dosage

Children >12 years and Adults: Oral: Initial: 250 mg 4 times/day, increased by 250-500 mg/day up to 4 g/day; maintenance: 2-3 g/day in 4 divided doses; for preoperative preparation, administer optimum effective dosage for 5-7 days


Dietary Considerations

Alcohol: Additive CNS effect, avoid use


Mental Health: Effects on Mental Status

Drowsiness and extrapyramidal reactions are common; may cause depression, hallucinations, or confusion


Mental Health: Effects on Psychiatric Treatment

Concurrent use with antipsychotics may increase the risk of extrapyramidal symptoms


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

No effects or complications reported


Patient Information

Take plenty of fluids each day; may cause drowsiness, impair coordination and judgment; notify physician if drooling, tremors, speech difficulty, or diarrhea occurs; avoid alcohol and central nervous system depressants


Nursing Implications

Administer plenty of fluids each day; may cause drowsiness, impair coordination and judgment; notify physician if drooling, tremors, speech difficulty, or diarrhea occurs; avoid alcohol and central nervous system depressants


Dosage Forms

Capsule: 250 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved